Advanced Search

 

Study ID Status Title Patient Level Data
105539 Completed An open, randomized, phase IIIa study to evaluate the safety and immunogenicity of GSK Biologicals' 10-valent pneumococcal conjugate vaccine, when administered intramuscularly according to a 2-4-11 months vaccination schedule Study Listed on ClinicalStudyDataRequest.com
105548 Completed A double-blind, randomized, placebo-controlled, repeat dose, 2-way crossover drug interaction study to investigate the pharmacokinetic and pharmacodynamic effects following administration of fluticasone furoate/GW642444M Inhalation Powder with ketoconazole Study Listed on ClinicalStudyDataRequest.com
105553 Completed Assess lot-to-lot consistency of 3 lots (double blind design) of GlaxoSmithKline Biologicals' 10-valent pneumococcal vaccine and evaluate non-inferiority to Prevenar™ (single blind design) when administered as 3-dose primary immunization course before 6 months of age Study Listed on ClinicalStudyDataRequest.com
105554 Completed Phase IIIa randomized, controlled study to assess the immunogenicity of GlaxoSmithKline (GSK) Biologicals’ 10-valent pneumococcal conjugate vaccine, when administered as a 3-dose primary immunization course before 6 months of age Study Listed on ClinicalStudyDataRequest.com
105555 Completed A phase II, multicentre booster study to evaluate booster vaccination with GSK Biologicals’ 10-valent pneumococcal conjugate vaccine or to evaluate the immune memory following the administration of a single dose of 23-valent plain polysaccharide vaccine in healthy children, previously vaccinated in infancy in the primary study 11PN-PD-DIT-002 (103488) Study Listed on ClinicalStudyDataRequest.com
105580 Completed Phase I Study of SB-497115-GR - Single and Multiple Oral Dose Study in Healthy Japanese Male Subjects - <Clinical Pharmacology Study>
105594 Terminated A phase II open label, multicenter study to evaluate the efficacy and safety of daily dose of Lapatinib in advanced breast cancer patients with HER-2 non-amplified primary tumours and HER-2 positive circulating tumour cells or EGFR positive circulating tumor cells
105-601 Completed An Open, Multicenter 48-Week Evaluation of LAMICTAL (lamotrigine) for Bipolar Disorder in Adult Patients
105640 Completed A 24-week, double-blind, double-dummy, randomized, parallel-group study to investigate the effects of rosiglitazone (extended release tablets), donepezil, and placebo as monotherapy on cognition and overall clinical response in APOE ε4-stratified subjects with mild to moderate Alzheimer’s disease. (REFLECT-1) Study Listed on ClinicalStudyDataRequest.com
105684 and 105685 Completed &amp;quot;GREAT (German Recent Evaluation of Avandamet Treatment)-Post Marketing Surveillance (PMS)
105695 Completed A Post-Marketing Surveillance (PMS) to monitor the safety of Wellbutrin SRTM (bupropion sustained-release) administered in Korean subjects according to the prescribing information
105700 Completed A Post-Marketing Surveillance to monitor the safety of SeretideTM (salmeterol-fluticasone propionate; SFC) administered in Korean subjects according to the prescribing information
105702 Completed A post-marketing surveillance to monitor the safety of Hycamtin (topotecan 4mg) adminstered in Korean subjects according to the prescribing information
105704 Completed A post-marketing surveillance to monitor the safety of Avandia (rosiglitazone) adminstered in Korean type 2 diabetes patients according to the prescribing information
105705 Completed A post-marketing surveillance to monitor the safety of CombivirTM (Lamivudine/Zidovudine)
105706 Completed A post-marketing surveillance to monitor the safety of Malarone (atovaquone 250mg and proguanil hydrochloride 100mg) adminstered in Korean subjects according to the prescribing information
105708 Completed A post-marketing surveillance to monitor the safety of Pritor(telmisartan 40mg and 80mg) adminstered in Korean subjects according to the prescribing information
105709 Completed An open label, multi-centre, non-interventional post-marketing surveillance to monitor the safety and/or efficacy of Avandamet® administered in Korean Diabetic patients according to the prescribing information
105711 Completed A post-marketing surveillance to monitor the safety of HEPSERA(adefovir dipivoxil 10mg) adminstered in Korean subjects according to the prescribing information
105721 Completed A long-term follow-up of a phase I/II study to compare the persistence and to perform in depth characterisation of the cellular and humoral immune response following vaccinations with GSK Biologicals' candidate vaccines containing HBsAg and different adjuvants in healthy adult volunteers
105722 Completed A placebo-controlled study to evaluate the immunogenicity, reactogenicity and safety of two doses of GSK Biologicals' oral live attenuated human rotavirus (HRV) liquid vaccine, when given to healthy infants, in Vietnam Study Listed on ClinicalStudyDataRequest.com
105736 Completed An Observational, Open-Label, Multicentre, Post-Marketing Surveillance Study on the Safety and Efficacy of Abacavir in Combination with Lamivudine in HIV-1 Infected, Therapy-Naïve Adults in Germany.
105753 Completed Safety & immunogenicity of a booster dose of dTPa vaccine (Boostrix®) co-admnd. with Aventis Pasteur’s meningococcal (serogroups A, C, Y and W-135) polysaccharide vaccine (Menactra™) vs admn. of either vaccine alone in healthy adolescents Study Listed on ClinicalStudyDataRequest.com
105757 Completed Study comparing the immunogenicity and safety of an investigational vaccination regimen to that of GSK Bio’s adjuvanted hepatitis B vaccine, Fendrix®, administered according to 0, 1, 2, 6 months schedule, in hepatitis B naïve pre-dialysis, peritoneal dialysis and haemodialysis patients (≥ 15 years of age)
105758 Completed Long-term follow-up study to evaluate the persistence of anti-HBs antibodies at Months 12, 24 and 36 in pre-dialysis / peritoneal dialysis or haemodialysis patients who had previously received a primary vaccination course of either an investigational vaccination regimen or GSK Biologicals' FendrixTM

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.